SANDRA OVIEDO: Open Payments
NPI 1053084905 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,987 in 209 payments from 38 companies in 2025. Trend: 2023 $4,399 · 2024 $5,634 · 2025 $4,987
Food & beverage: $4,965Education: $22
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $755 |
| Biogen, Inc. | 27 | $576 |
| ARGENX US, INC. | 13 | $431 |
| Lundbeck LLC | 14 | $340 |
| UCB, Inc. | 9 | $261 |
| EMD Serono, Inc. | 6 | $240 |
| Eisai Inc. | 19 | $198 |
| Lilly USA, LLC | 7 | $195 |
| Neurocrine BioSciences, Inc. | 1 | $170 |
| Celgene Corporation | 7 | $139 |
Products named: VYVGART HYTRULO, TYSABRI, QULIPTA, UBRELVY, Leqembi, REXULTI, VYEPTI, VYALEV.
Industry payments across NV — which companies pay providers there.
